Santhera Pharmaceuticals Holding AG Stock Xetra
Equities
S3F
CH0027148649
Pharmaceuticals
Sales 2024 * | 37.55M 41.96M 38.47M | Sales 2025 * | 60M 67.05M 61.47M | Capitalization | 77.31M 86.4M 79.21M |
---|---|---|---|---|---|
Net income 2024 * | -35M -39.11M -35.86M | Net income 2025 * | -10M -11.17M -10.24M | EV / Sales 2024 * | 2.06 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.29 x |
P/E ratio 2024 * |
-2.99
x | P/E ratio 2025 * |
-11.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on Santhera Pharmaceuticals Holding AG
Managers | Title | Age | Since |
---|---|---|---|
Dario Eklund
CEO | Chief Executive Officer | 56 | 19-11-30 |
Thomas Meier
FOU | Founder | 62 | 04-09-06 |
Andrew Smith
DFI | Director of Finance/CFO | 61 | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Meier
FOU | Founder | 62 | 04-09-06 |
Director/Board Member | 56 | 17-04-03 | |
Otto Schwarz
BRD | Director/Board Member | 68 | 23-06-26 |
1st Jan change | Capi. | |
---|---|---|
+7.04% | 73.13B | |
+31.10% | 10.38B | |
+37.94% | 5.16B | |
-17.33% | 4.73B | |
+21.49% | 3.81B | |
+24.92% | 2.26B | |
-36.84% | 1.88B | |
-43.31% | 1.77B | |
-0.50% | 1.64B |